FORTE BIOSCIENCES INC's ticker is FBRX and the CUSIP is 34962G109. A total of 33 filers reported holding FORTE BIOSCIENCES INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $93,899 | -22.9% | 174,858 | 0.0% | 0.00% | – |
Q1 2024 | $121,736 | -18.7% | 174,858 | -4.1% | 0.00% | – |
Q4 2023 | $149,815 | +24.2% | 182,324 | +0.1% | 0.00% | – |
Q3 2023 | $120,592 | -36.4% | 182,164 | -0.1% | 0.00% | – |
Q2 2023 | $189,619 | -1.9% | 182,326 | -4.7% | 0.00% | – |
Q1 2023 | $193,321 | -8.8% | 191,407 | -9.7% | 0.00% | – |
Q4 2022 | $211,876 | -6.2% | 211,876 | -0.1% | 0.00% | – |
Q3 2022 | $226,000 | -18.7% | 212,061 | -0.9% | 0.00% | – |
Q2 2022 | $278,000 | -76.4% | 214,043 | -73.4% | 0.00% | – |
Q1 2022 | $1,176,000 | -32.7% | 806,015 | -1.4% | 0.00% | – |
Q4 2021 | $1,748,000 | -23.5% | 817,063 | +5.9% | 0.00% | – |
Q3 2021 | $2,284,000 | -91.2% | 771,726 | -0.4% | 0.00% | -100.0% |
Q2 2021 | $26,059,000 | +190.6% | 775,119 | +196.2% | 0.00% | – |
Q1 2021 | $8,968,000 | +62.8% | 261,669 | +73.0% | 0.00% | – |
Q4 2020 | $5,507,000 | +7.9% | 151,253 | +43.8% | 0.00% | – |
Q3 2020 | $5,102,000 | +607.6% | 105,164 | +112.7% | 0.00% | – |
Q2 2020 | $721,000 | – | 49,441 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Altium Capital Management LP | 134,542 | $4,611,000 | 1.28% |
Asymmetry Capital Management, L.P. | 53,197 | $1,823,000 | 0.94% |
BVF INC/IL | 718,788 | $24,633,000 | 0.92% |
ArrowMark Colorado Holdings LLC | 1,394,564 | $47,792,000 | 0.36% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 600,000 | $20,562,000 | 0.30% |
Perceptive Advisors | 685,000 | $23,475,000 | 0.30% |
MYDA Advisors LLC | 28,000 | $960,000 | 0.27% |
Parkman Healthcare Partners LLC | 31,256 | $1,071,000 | 0.25% |
Endurant Capital Management LP | 27,591 | $946,000 | 0.25% |
Insight Advisors, LLC/ PA | 19,030 | $689,000 | 0.22% |